Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

被引：194
作者：
Winter, Jordan M. [1 ]
Yeo, Charles J. [1 ]
Brody, Jonathan R. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2013年 / 107卷 / 01期
关键词：
pancreatic cancer; pancreatic ductal adenocarcinoma; biomarkers; predictive markers; prognostic markers; SERUM CA-19-9 LEVELS; GENE-EXPRESSION; ADJUVANT CHEMOTHERAPY; PHOSPHOGLYCERATE KINASE-1; DUCTAL ADENOCARCINOMA; CA19-9; LEVELS; SURVIVAL; GEMCITABINE; RECURRENCE; IDENTIFICATION;
D O I：
10.1002/jso.23192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serum CA 19-9 is the only FDA approved biomarker recommended for use in the routine management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies related to pancreatic cancer appear in the literature, highlighting the need to discover and develop improved tests. Diagnostic biomarkers have implications for early detection of PDA, prognostic markers predict patient survival and recurrence patterns, and predictive markers can help personalize treatment regimens. J. Surg. Oncol. 2013;107:1522. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 50 条
  • [41] Potential Prognostic Biomarkers of Pancreatic Cancer
    Chen, Kathryn T.
    Kim, Phillip D.
    Jones, Kelly A.
    Devarajan, Karthik
    Patel, Bhavinkumar B.
    Hoffman, John P.
    Ehya, Hormoz
    Huang, Min
    Watson, James C.
    Tokar, Jeffrey L.
    Yeung, Anthony T.
    PANCREAS, 2014, 43 (01) : 22 - 27
  • [42] Prognostic impact of inflammatory and nutritional biomarkers in pancreatic cancer
    Teja, Macarena
    Garrido, Maria, I
    Ocanto, Abrahams
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2025, 16 (01):
  • [43] Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade
    Koenig, Anna-Katharina
    Gros, Helene
    Hinz, Ulf
    Hank, Thomas
    Kaiser, Joerg
    Hackert, Thilo
    Bergmann, Frank
    Buechler, Markus W.
    Strobel, Oliver
    EJSO, 2022, 48 (01): : 113 - 120
  • [44] Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers
    Huang, Tao
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (01): : 1 - 11
  • [45] CASE REVIEW Tumour biomarkers: diagnostic, prognostic, and predictive
    Shaw, Abigail
    Bradley, Marcus D.
    Elyan, Sean
    Kurian, Kathreena M.
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [46] The prognostic value of Cyclin B1 in pancreatic cancer
    Zhou, Li
    Li, Jian
    Zhao, Yu-Pei
    Cui, Quan-Cai
    Zhou, Wei-Xun
    Guo, Jun-Chao
    You, Lei
    Wu, Wen-Ming
    Zhang, Tai-Ping
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [47] Prognostic factors in patients with pancreatic cancer
    Zhang, De-Xiang
    Dai, Yue-Di
    Yuan, Su-Xu
    Tao, Li
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (03) : 423 - 432
  • [48] Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy
    Maeda, Shimpei
    Ariake, Kyohei
    Iseki, Masahiro
    Ohtsuka, Hideo
    Mizuma, Masamichi
    Nakagawa, Kei
    Morikawa, Takanori
    Hayashi, Hiroki
    Motoi, Fuyuhiko
    Kamei, Takashi
    Naitoh, Takeshi
    Unno, Michiaki
    SURGERY TODAY, 2020, 50 (05) : 490 - 498
  • [49] Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
    Tarasiuk, Aleksandra
    Mackiewicz, Tomasz
    Malecka-Panas, Ewa
    Fichna, Jakub
    CANCER BIOLOGY & THERAPY, 2021, 22 (5-6) : 347 - 356
  • [50] NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer
    Hoshikawa, Mayumi
    Aoki, Taku
    Matsushita, Hirokazu
    Karasaki, Takahiro
    Hosoi, Akihiro
    Odaira, Kosuke
    Fujieda, Nao
    Kobayashi, Yukari
    Kambara, Kaori
    Ohara, Osamu
    Arita, Junichi
    Hasegawa, Kiyoshi
    Kakimi, Kazuhiro
    Kokudo, Norihiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (02) : 2058 - 2065
12345